Abstract |
A series of novel N-arylalkyl-3,4-diaryl-substituted pyrrole-2,5-diones were synthesized. They exhibited promising P-gp modulating activity in a P-gp overexpressing breast cancer cell line (LCC6MDR). Compound 6 (with three methoxy groups at D-ring) displayed the highest P-gp modulating activity. 6 at 1 microM can sensitize LCC6MDR cells toward paclitaxel by 18.2-fold. Interestingly, a synergy on modulating P-gp was noted when 6 and 25 were used together (fractional inhibitory concentration index FICI = 0.42). Combination of 6 (0.5 microM) and 25 (0.5 microM) resulted in a 66-fold sensitization of LCC6MDR cells toward paclitaxel. They also reversed P-gp mediated doxorubicin (DOX) and vincristine resistance. Kinetic characterization suggests that permethyl ningalin B analogues likely act as a noncompetitive inhibitor of P-gp-mediated DOX transport (K(i) = 5.4-5.8 microM). The present study demonstrates that synthetic analogues of permethyl ningalin B can be employed as effective and safe modulators of P-gp-mediated drug resistance in cancer cells.
|
Authors | Pu Yong Zhang, Iris L K Wong, Clare S W Yan, Xiao Yu Zhang, Tao Jiang, Larry M C Chow, Sheng Biao Wan |
Journal | Journal of medicinal chemistry
(J Med Chem)
Vol. 53
Issue 14
Pg. 5108-20
(Jul 22 2010)
ISSN: 1520-4804 [Electronic] United States |
PMID | 20560605
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- ATP Binding Cassette Transporter, Subfamily B, Member 1
- Antineoplastic Agents
- Heterocyclic Compounds, 3-Ring
- Pyrroles
- ningalin B
- Vincristine
- Doxorubicin
- Paclitaxel
|
Topics |
- ATP Binding Cassette Transporter, Subfamily B, Member 1
(biosynthesis)
- Antineoplastic Agents
(chemical synthesis, chemistry, pharmacology)
- Cell Line, Tumor
- Doxorubicin
(pharmacology)
- Drug Design
- Drug Resistance, Multiple
(drug effects)
- Drug Resistance, Neoplasm
(drug effects)
- Heterocyclic Compounds, 3-Ring
(chemical synthesis, chemistry, pharmacology)
- Humans
- Paclitaxel
(pharmacology)
- Pyrroles
(chemical synthesis, chemistry, pharmacology)
- Stereoisomerism
- Structure-Activity Relationship
- Vincristine
(pharmacology)
|